BOCA RATON, Fla., Nov. 13, 2014 (GLOBE NEWSWIRE) -- Emergent Health Corp. (Pinks, OTC Markets:EMGE) (the "Company") announced today it has moved its corporate office to 2424 North Federal Highway, suite 257 Boca Raton, Florida from King of Prussia, PA. This move is intended to provide greater visibility and corporate space for expansion. All corporate inquiries should go to this address and to the corporate number 561-465-2042.
The Company believes there are several other noteworthy events that have taken place since its last news release:
- The Company has engaged SEC Counsel to file an S-1 Registration Statement. The goal of this S-1 is to raise the level of the Company to become reporting. It is believed that upon attainment of this objective, the Company could be enabled to not only raise additional funds for expansion but also help to increase current stock liquidity. A further release will be made once the S-1 Registration Statement is filed.
- Part of this SEC Counsel engagement included the engagement of a Public Company Accounting Oversight Board registered auditing firm to complete a Financial Audit to accompany the S-1 Registration Statement.
- The Company is in process of revising the marketing of the patented and patent pending Stem Cell Nutrition product line for which it is licensed by forming a new Division known as Cellaviv. It is believed this new approach along with exciting new product entries related to Cancer Nutritional Support as well as a new approach to weight loss for those suffering with obesity could be a major factor in future growth.
The Company believes it is in a key position to make new strides in 2015 and beyond.
This press release contains certain "forward-looking" statements, defined in the United States Private Securities Litigation Reform Act of 1995, that involve a number of risks and uncertainties. Statements, which are not historical facts, are forward-looking statements. The company, through its management, makes forward-looking public statements concerning its expected future operations, performance and other developments. Such forward-looking statements are estimates reflecting the company's best judgment based upon current information and involve a number of risks and uncertainties, and there can be no assurance that other factors will not affect the accuracy of such forward-looking statements. It is impossible to identify all such factors, factors that could cause actual results to differ materially from those estimated by the company. This press release is provided for information purposes only and is not intended to constitute an offer to sell or a solicitation of an offer to buy securities.
CONTACT: Emergent Health Corp. 561-465-2042Source:Emergent Health Corp.